Takinib   Click here for help

GtoPdb Ligand ID: 9655

PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Takinib is a potent, ATP-competitive and selective inhibitor of the TAK1 kinase (MAP3K7) [2]. It is reported to sensitize cells to TNF-α-induced apoptosis, an effect that has potential application in oncology and autoimmune disease treatment.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 72.52
Molecular weight 322.14
XLogP 4.17
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES CCCn1c(=NC(=O)c2cccc(c2)C(=O)N)[nH]c2c1cccc2
Isomeric SMILES CCCn1/c(=N/C(=O)c2cccc(c2)C(=O)N)/[nH]c2c1cccc2
InChI InChI=1S/C18H18N4O2/c1-2-10-22-15-9-4-3-8-14(15)20-18(22)21-17(24)13-7-5-6-12(11-13)16(19)23/h3-9,11H,2,10H2,1H3,(H2,19,23)(H,20,21,24)
InChI Key UOZVVPXKJGOFIG-UHFFFAOYSA-N
Immunopharmacology Comments
TAK1 (MAP3K7) is an evolutionarily conserved regulator of pro survival signaling mediated by the TNF-α pathway that is implicated in several cancer types and inflammatory disorders. Pharmacological inhibition of TAK1 is considered as a novel intervention point with potential utility in oncology and the treatment of autoimmune diseases. Takinib is an experimental inhibitor designed to validate this mechanism. Indeed, Scarneo et al. (2018) used Takinib to validate TAK1 inhibition as a therapeutic strategy that can effectively inhibit macrophage TNF secretion, in in vitro and in vivo models [1]. This work identified that Takinib suppressed TNF production from invading macrophages at sites of inflammation.